Carlos Solano

38PUBLICATIONS
143CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jun 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

|Jan 26, 2026
Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing.

Rafael Hernani, Eliseo Albert, Carlos Hernani-Morales

|Jan 13, 2026
Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study.

Marta Peña, Giulia Losi, Víctor Navarro

|Sep 12, 2025
Pre-infusion cytomegalovirus T-cell immunity for predicting the risk of virus DNAemia in patients undergoing chimeric antigen receptor T-cell therapies.

Eliseo Albert, Rafael Hernani, Estela Giménez

|Aug 28, 2025
Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients.

Aitor Gonzaga, Gema Martinez-Navarrete, Loreto Macia

|Jul 25, 2025
Natural Killer (NK) Cell Alloreactivity in Haploidentical Stem Cell Transplantation.

Mar Luis-Hidalgo, José Luis Piñana, Carlos Solano

Pageof 7

Frequent Collaborators

16 joint publications

Dixie Huntley

12 joint publications

José Luis Piñana

12 joint publications

Juan Carlos Hernández-Boluda

6 joint publications

Jaime Sanz